NervGen Pharma (NGENF) Q3 2024 Earnings

22AugConfirmed
Aug 22
Nov 22
Q2 2024
Q3 2024
-0.14
-0.1
-0.07
-0.03

Details

Expected EPS
-0.065763
Actual EPS
-0.080377
Surprise EPS
-0.01
Surprise Percent
+22.22%

Description

NervGen Pharma (NGENF) has reported earnings of -0.080377 per share for Q3 2024.

0 Comments

Share your thoughts